In contrast, acquired resistance develops progressively during chemotherapy and may involve mechanisms such as upregulation of drug efflux pumps (e.g., P-glycoprotein), suppression of apoptosis pathways, or alterations in the tumor microenvironment [6]. This evidence concerns the gene ABCB1 and neoplasm.